Published in J Clin Invest on March 27, 2017
Oxygen availability and metabolic reprogramming in cancer. J Biol Chem (2017) 0.92
Kidney cancer: Targeting metabolism in RCC. Nat Rev Nephrol (2017) 0.75
Why do cancers have high aerobic glycolysis? Nat Rev Cancer (2004) 20.60
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature (2005) 19.13
The DNA damage response: making it safe to play with knives. Mol Cell (2010) 16.13
Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature (2013) 13.60
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature (2009) 13.28
HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab (2006) 13.22
Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res (2010) 12.96
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab (2006) 10.14
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature (2011) 7.94
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell (2012) 7.36
PARP inhibition: PARP1 and beyond. Nat Rev Cancer (2010) 6.70
Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature (2011) 6.57
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature (2013) 6.53
Mutagenic deamination of cytosine residues in DNA. Nature (1980) 6.26
HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell (2007) 6.16
Replicon clusters are stable units of chromosome structure: evidence that nuclear organization contributes to the efficient activation and propagation of S phase in human cells. J Cell Biol (1998) 6.12
Targeting metabolic transformation for cancer therapy. Nat Rev Cancer (2010) 5.90
Links between metabolism and cancer. Genes Dev (2012) 5.27
Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci U S A (2011) 5.24
Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell (2011) 4.83
Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab (2012) 4.80
The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer (2008) 4.42
Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci U S A (2010) 4.18
A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc (2012) 3.87
The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab (2012) 3.81
Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest (2013) 3.46
Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science (2013) 2.90
The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4. Cell (2013) 2.70
The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr Opin Genet Dev (2009) 2.54
Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer. Cancer Discov (2012) 2.53
Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA. Proc Natl Acad Sci U S A (2002) 2.46
Visualization of altered replication dynamics after DNA damage in human cells. J Biol Chem (2004) 2.41
Intracellular α-ketoglutarate maintains the pluripotency of embryonic stem cells. Nature (2014) 2.19
Measurement of cell proliferation by labeling of DNA with stable isotope-labeled glucose: studies in vitro, in animals, and in humans. Proc Natl Acad Sci U S A (1998) 2.05
Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol Cancer Ther (2014) 2.03
Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proc Natl Acad Sci U S A (2012) 2.02
In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation. Cell Metab (2013) 1.93
Acetate dependence of tumors. Cell (2014) 1.80
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition. Blood (2015) 1.79
Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism. J Biol Chem (1983) 1.74
DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb Perspect Biol (2013) 1.72
ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. Cancer Cell (2012) 1.71
Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies. Cancer Cell (2015) 1.70
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis. J Clin Invest (2015) 1.67
The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol Biol Cell (2010) 1.49
Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathways. Cancer Metab (2014) 1.45
Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation. Mol Cell (2014) 1.26
Isoenzyme-specific regulation of genes involved in energy metabolism by hypoxia: similarities with the regulation of erythropoietin. Biochem J (1996) 1.15
Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment. J Clin Invest (2015) 1.15
Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res (2015) 1.08
Discovery of small-molecule enhancers of reactive oxygen species that are nontoxic or cause genotype-selective cell death. ACS Chem Biol (2013) 0.99
Cell cycle-dependent regulation of pyrimidine biosynthesis. J Biol Chem (2002) 0.96
ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation. J Cell Biochem (2014) 0.92
Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone. Cancer Metab (2015) 0.88
Synthetic lethality of combined glutaminase and Hsp90 inhibition in mTORC1-driven tumor cells. Proc Natl Acad Sci U S A (2014) 0.87
Putting poly (ADP-ribose) polymerase and other DNA repair inhibitors into clinical practice. Curr Opin Oncol (2013) 0.84
Regulation of CAD gene expression in mouse fibroblasts during the transition from the resting to the growing state. Exp Cell Res (1988) 0.84
The mechanism of succinate or fumarate transfer in the tricarboxylic acid cycle allows molecular rotation of the intermediate. Arch Biochem Biophys (1990) 0.81
Phosphorylation, allosteric effectors and inter-domain contacts in CAD; their role in regulation of early steps of pyrimidine biosynthesis. Biochem Soc Trans (1993) 0.76
A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell (2010) 11.20
Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab (2008) 7.97
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature (2011) 7.94
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet (2011) 6.89
Truncations of titin causing dilated cardiomyopathy. N Engl J Med (2012) 6.07
The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell (2010) 5.11
Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science (2010) 4.96
RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models. Cancer Res (2010) 4.70
Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. Nat Med (2005) 4.27
Tuning genetic control through promoter engineering. Proc Natl Acad Sci U S A (2005) 4.07
Checking on the fork: the DNA-replication stress-response pathway. Trends Cell Biol (2002) 3.66
Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci U S A (2005) 3.49
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat Chem Biol (2012) 3.40
Engineering yeast transcription machinery for improved ethanol tolerance and production. Science (2006) 3.30
Elementary metabolite units (EMU): a novel framework for modeling isotopic distributions. Metab Eng (2006) 3.23
Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. Mol Syst Biol (2011) 3.15
Single-stranded DNA orchestrates an ATM-to-ATR switch at DNA breaks. Mol Cell (2009) 3.12
Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab (2013) 3.01
Construction of lycopene-overproducing E. coli strains by combining systematic and combinatorial gene knockout targets. Nat Biotechnol (2005) 2.95
Help wanted. Ann Thorac Surg (2003) 2.88
Determination of confidence intervals of metabolic fluxes estimated from stable isotope measurements. Metab Eng (2006) 2.79
Quantifying reductive carboxylation flux of glutamine to lipid in a brown adipocyte cell line. J Biol Chem (2008) 2.76
Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res (2009) 2.74
The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4. Cell (2013) 2.70
Management of lymph node-positive prostate cancer: the role of surgery and radiation therapy. Oncology (Williston Park) (2013) 2.40
Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis. Nat Genet (2012) 2.39
CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase. Mol Cell (2010) 2.29
Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors. Mol Cancer Res (2004) 2.27
Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow. Arterioscler Thromb Vasc Biol (2006) 2.22
Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation. Genes Dev (2011) 2.20
TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA. Nature (2011) 2.17
Small-molecule inhibitors of HIF-2a translation link its 5'UTR iron-responsive element to oxygen sensing. Mol Cell (2008) 2.15
Engineering for biofuels: exploiting innate microbial capacity or importing biosynthetic potential? Nat Rev Microbiol (2009) 2.13
Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells. J Biotechnol (2009) 2.08
Interactive exploration of microarray gene expression patterns in a reduced dimensional space. Genome Res (2002) 2.07
Physician roles in the cancer-related follow-up care of cancer survivors. Fam Med (2013) 2.00
Regulation of homologous recombination by RNF20-dependent H2B ubiquitination. Mol Cell (2011) 2.00
Accurate assessment of amino acid mass isotopomer distributions for metabolic flux analysis. Anal Chem (2007) 1.99
An elementary metabolite unit (EMU) based method of isotopically nonstationary flux analysis. Biotechnol Bioeng (2008) 1.98
Noninvasive methods to evaluate bladder obstruction in men. Int Braz J Urol (2013) 1.98
Prosthesis-patient mismatch in bovine pericardial aortic valves: evaluation using 3 different modalities and associated medium-term outcomes. Circ Cardiovasc Imaging (2013) 1.97
ATR: a master conductor of cellular responses to DNA replication stress. Trends Biochem Sci (2010) 1.96
Point: Minimally invasive bipolar radiofrequency ablation of lone atrial fibrillation: early multicenter results. J Thorac Cardiovasc Surg (2009) 1.95
First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Negl Trop Dis (2008) 1.93
In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation. Cell Metab (2013) 1.93
The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis. J Pediatr Urol (2010) 1.86
A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions. Cancer Cell (2011) 1.86
Global transcription machinery engineering: a new approach for improving cellular phenotype. Metab Eng (2007) 1.81
Selection and optimization of microbial hosts for biofuels production. Metab Eng (2008) 1.80
The Shang Ring device for adult male circumcision: a proof of concept study in Kenya. J Acquir Immune Defic Syndr (2011) 1.80
CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance. J Lipid Res (2010) 1.79
Linking high-resolution metabolic flux phenotypes and transcriptional regulation in yeast modulated by the global regulator Gcn4p. Proc Natl Acad Sci U S A (2009) 1.79
Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer. Cancer Res (2004) 1.76
The acceptability and safety of the Shang Ring for adult male circumcision in Rakai, Uganda. J Acquir Immune Defic Syndr (2013) 1.74
Characterization of monospecies biofilm formation by Helicobacter pylori. J Bacteriol (2004) 1.72
DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb Perspect Biol (2013) 1.72
ATR autophosphorylation as a molecular switch for checkpoint activation. Mol Cell (2011) 1.70
Engineering the push and pull of lipid biosynthesis in oleaginous yeast Yarrowia lipolytica for biofuel production. Metab Eng (2012) 1.69
Multi-dimensional gene target search for improving lycopene biosynthesis in Escherichia coli. Metab Eng (2007) 1.68
Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells. Nat Commun (2013) 1.68
Determination of minimum sample size and discriminatory expression patterns in microarray data. Bioinformatics (2002) 1.68
Combining metabolic and protein engineering of a terpenoid biosynthetic pathway for overproduction and selectivity control. Proc Natl Acad Sci U S A (2010) 1.65
Rad17 phosphorylation is required for claspin recruitment and Chk1 activation in response to replication stress. Mol Cell (2006) 1.65
Effect of a risk-stratified grade of nerve-sparing technique on early return of continence after robot-assisted laparoscopic radical prostatectomy. Eur Urol (2012) 1.65
Stabilized gene duplication enables long-term selection-free heterologous pathway expression. Nat Biotechnol (2009) 1.65
Genomic instability and endoreduplication triggered by RAD17 deletion. Genes Dev (2003) 1.64
Terpenoids: opportunities for biosynthesis of natural product drugs using engineered microorganisms. Mol Pharm (2008) 1.60
Elucidation of gene interaction networks through time-lagged correlation analysis of transcriptional data. Genome Res (2004) 1.59
Nontargeted elucidation of metabolic pathways using stable-isotope tracers and mass spectrometry. Anal Chem (2010) 1.57
Metabolic flux analysis in a nonstationary system: fed-batch fermentation of a high yielding strain of E. coli producing 1,3-propanediol. Metab Eng (2007) 1.56
ATRIP associates with replication protein A-coated ssDNA through multiple interactions. Proc Natl Acad Sci U S A (2006) 1.55
Contemporary perioperative results of isolated aortic valve replacement for aortic stenosis. Ann Thorac Surg (2010) 1.55
Future direction in pharmacotherapy for non-neurogenic male lower urinary tract symptoms. Eur Urol (2013) 1.54
Mapping photoautotrophic metabolism with isotopically nonstationary (13)C flux analysis. Metab Eng (2011) 1.53
Progressive calcified tuber in a young male with tuberous sclerosis complex. Dev Med Child Neurol (2010) 1.53
Engineering of promoter replacement cassettes for fine-tuning of gene expression in Saccharomyces cerevisiae. Appl Environ Microbiol (2006) 1.53
Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomised controlled trials. Int J Cardiol (2008) 1.51
Chk1 and Claspin potentiate PCNA ubiquitination. Genes Dev (2008) 1.51
Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism. Cancer Res (2013) 1.49
High-throughput metabolic state analysis: the missing link in integrated functional genomics of yeasts. Biochem J (2005) 1.47
IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore) (2013) 1.47
Sternal salvage with rigid plating system after failure of talon device. Ann Thorac Surg (2010) 1.44
A linguistic model for the rational design of antimicrobial peptides. Nature (2006) 1.44
Randomized trial of the Shang Ring for adult male circumcision with removal at one to three weeks: delayed removal leads to detachment. J Acquir Immune Defic Syndr (2012) 1.43
Should paroxysmal atrial fibrillation be treated during cardiac surgery? J Thorac Cardiovasc Surg (2013) 1.43
Is there a place for levosimendan in the intensive care unit? Crit Care Resusc (2007) 1.42
The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling. Cancer Res (2010) 1.41
Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. EMBO Mol Med (2009) 1.41
The future of metabolic engineering and synthetic biology: towards a systematic practice. Metab Eng (2012) 1.40
Sustained supervised practice on a coronary anastomosis simulator increases medical student interest in surgery, unsupervised practice does not. Ann Thorac Surg (2013) 1.39
L-tyrosine production by deregulated strains of Escherichia coli. Appl Microbiol Biotechnol (2007) 1.39
Optimization of a heterologous pathway for the production of flavonoids from glucose. Metab Eng (2011) 1.38
Combinatorial pathway analysis for improved L-tyrosine production in Escherichia coli: identification of enzymatic bottlenecks by systematic gene overexpression. Metab Eng (2007) 1.36
Case records of the Massachusetts General Hospital. Case 22-2006--a 77-year-old man with a rapidly progressive gait disorder. N Engl J Med (2006) 1.36
Improvement of xylose uptake and ethanol production in recombinant Saccharomyces cerevisiae through an inverse metabolic engineering approach. Appl Environ Microbiol (2005) 1.36